170 related articles for article (PubMed ID: 18398933)
1. Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120.
Mirano-Bascos D; Tary-Lehmann M; Landry SJ
Eur J Immunol; 2008 May; 38(5):1231-7. PubMed ID: 18398933
[TBL] [Abstract][Full Text] [Related]
2. Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120.
Nguyen HN; Steede NK; Robinson JE; Landry SJ
Vaccine; 2015 Jun; 33(25):2887-96. PubMed ID: 25944298
[TBL] [Abstract][Full Text] [Related]
3. Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120.
Dai G; Steede NK; Landry SJ
J Biol Chem; 2001 Nov; 276(45):41913-20. PubMed ID: 11551929
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein.
Li T; Steede NK; Nguyen HN; Freytag LC; McLachlan JB; Mettu RR; Robinson JE; Landry SJ
J Virol; 2014 Sep; 88(17):9605-15. PubMed ID: 24920818
[TBL] [Abstract][Full Text] [Related]
5. Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes.
Li H; Xu CF; Blais S; Wan Q; Zhang HT; Landry SJ; Hioe CE
J Immunol; 2009 May; 182(10):6369-78. PubMed ID: 19414790
[TBL] [Abstract][Full Text] [Related]
6. Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.
Pozzi G; Oggioni MR; Manganelli R; Medaglini D; Fischetti VA; Fenoglio D; Valle MT; Kunkl A; Manca F
Vaccine; 1994 Sep; 12(12):1071-7. PubMed ID: 7998415
[TBL] [Abstract][Full Text] [Related]
7. Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120.
Landry SJ
J Theor Biol; 2000 Apr; 203(3):189-201. PubMed ID: 10716904
[TBL] [Abstract][Full Text] [Related]
8. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
9. T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry.
Brown SA; Lockey TD; Slaughter C; Slobod KS; Surman S; Zirkel A; Mishra A; Pagala VR; Coleclough C; Doherty PC; Hurwitz JL
AIDS Res Hum Retroviruses; 2005 Feb; 21(2):165-70. PubMed ID: 15725756
[TBL] [Abstract][Full Text] [Related]
10. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
[TBL] [Abstract][Full Text] [Related]
11. Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120.
Mirano-Bascos D; Steede NK; Robinson JE; Landry SJ
J Virol; 2010 Apr; 84(7):3303-11. PubMed ID: 20089653
[TBL] [Abstract][Full Text] [Related]
12. Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes.
Carmicle S; Steede NK; Landry SJ
Mol Immunol; 2007 Feb; 44(6):1159-68. PubMed ID: 16893568
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a trimeric gp120 epitope mimic conjugated to a T-helper peptide to improve antigenicity.
Schellinger JG; Danan-Leon LM; Hoch JA; Kassa A; Srivastava I; Davis D; Gervay-Hague J
J Am Chem Soc; 2011 Mar; 133(10):3230-3. PubMed ID: 21341746
[TBL] [Abstract][Full Text] [Related]
14. Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.
Frey BF; Jiang J; Sui Y; Boyd LF; Yu B; Tatsuno G; Billeskov R; Solaymani-Mohammadi S; Berman PW; Margulies DH; Berzofsky JA
J Immunol; 2018 Mar; 200(5):1853-1864. PubMed ID: 29374075
[TBL] [Abstract][Full Text] [Related]
15. Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations.
Newman MJ; Wu JY; Gardner BH; Anderson CA; Kensil CR; Recchia J; Coughlin RT; Powell MF
Vaccine; 1997 Jun; 15(9):1001-7. PubMed ID: 9261947
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for helper T-cell and antibody epitope immunodominance in bacteriophage T4 Hsp10. Role of disordered loops.
Dai G; Carmicle S; Steede NK; Landry SJ
J Biol Chem; 2002 Jan; 277(1):161-8. PubMed ID: 11602571
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response to immunocomplexed HIV envelope glycoprotein 120.
Denisova G; Stern B; Raviv D; Zwickel J; Smorodinsky NI; Gershoni JM
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):901-9. PubMed ID: 8798975
[TBL] [Abstract][Full Text] [Related]
18. The immunologic dominance of an epitope within a rationally designed poly-epitope vaccine is influenced by multiple factors.
Shu J; Shen W; Liu H; Zhou Y; Li J; Zhuang Y; Huang Z; Yin S; Jiang L; Sun Y; Jin X; Xu J
Vaccine; 2020 Mar; 38(14):2913-2924. PubMed ID: 32127225
[TBL] [Abstract][Full Text] [Related]
19. Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.
Pan R; Qin Y; Banasik M; Lees W; Shepherd AJ; Cho MW; Kong XP
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343576
[TBL] [Abstract][Full Text] [Related]
20. Avidity of CD8 T cells sharpens immunodominance.
Dzutsev AH; Belyakov IM; Isakov DV; Margulies DH; Berzofsky JA
Int Immunol; 2007 Apr; 19(4):497-507. PubMed ID: 17376783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
